Spero Therapeutics Stock (NASDAQ: SPRO) stock price, news, charts, stock research, profile.
Open | $1.660 |
Close | $1.690 |
Volume / Avg. | 112.513K / 315.948K |
Day Range | 1.650 - 1.700 |
52 Wk Range | 0.990 - 1.995 |
Market Cap | $92.157M |
P/E Ratio | 3.884 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 1.16% |
Days to Cover | 2.15 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Spero Therapeutics (NASDAQ: SPRO) through any online brokerage.
Other companies in Spero Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), HOOKIPA Pharma (NASDAQ:HOOK), Connect Biopharma Hldgs (NASDAQ:CNTB), Curis (NASDAQ:CRIS) and Burning Rock Biotech (NASDAQ:BNR).
The latest price target for Spero Therapeutics (NASDAQ: SPRO) was reported by Cantor Fitzgerald on Thursday, April 4, 2024. The analyst firm set a price target for 0.00 expecting SPRO to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for Spero Therapeutics (NASDAQ: SPRO) is $1.71 last updated Today at May 9, 2024 at 12:16 AM EDT.
A quarterly cash dividend of $0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on October 7, 2015 to stockholders of record on September 16, 2015.
Spero Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Spero Therapeutics.
Spero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.